Susan Hasty, Publisher
Table of Contents . . . September 6th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Measles - Human Parainfluenza Virus Type 3 Used to Make Vaccine
HIV Vaccines - HIV-1 Specific Immune Responses Generated by Vaccine and Booster
Cancer Therapies - Combined Antibody/Antivascular Therapy Eradicates Tumors in Mouse Model
Pneumococcal Vaccines - Immediate Response to Skin Test is Good Predictor of Anaphylaxis
Travel Medicine - Booster Doses of Hepatitis A Vaccine Effective Even When Given 56 Months Apart
Adverse Drug Effects - Pseudothrombocytopenia in Abciximab Therapy Examined
Allergy Medicine - Experts Say Shots Should Be Used More Frequently in Allergic Asthma to Prevent Disease
Conference Announcement - Ohio State to Host First Worldwide Biomed/Nanotech Meeting
Diabetes - Vaccine Approved for Phase II Study
Drug Development - Collaboration Announced to Develop Antibody Therapeutics
Foodborne Illness - U.S. Navy to Fund Phase III Trial of Campylobacter Vaccine
Gene Expression - Discovery in Proprietary DNA Delivery System Announced
Human B-Cell Lymphoma - Antibody Therapy Highly Potent in Murine Model
Ovarian Cancer - Immunotoxin Targets Mesothelin, Effective in Animal Models
Rabies - Researchers Say Shots Often Overused
Typhoid Fever - Patent License Received on Oral Vaccine
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.